CJC-1295

CJC-1295 2 mg

10 Vials

Royal Pharma CJC-1295 contains CJC-1295 2 mg per vial. CJC-1295 is a synthetic peptide that has been investigated in clinical and laboratory research for its interaction with growth hormone-releasing hormone (GHRH) receptors. It is an investigational peptide and is not approved as a prescription medicine in many jurisdictions.

Product Specifications

• Active Ingredient: CJC-1295

• Strength: 2 mg per vial

• Dosage Form: Lyophilized powder for reconstitution

• Pack Size: 10 Vials

• Brand: Royal Pharma

Quality Standards

• Manufactured under strict quality control procedures

• High-purity raw materials

• Precision manufacturing for batch-to-batch consistency

• Comprehensive quality assurance and product traceability

• Sterile, tamper-evident vial packaging

Storage

Store refrigerated at 2–8°C. Protect from direct light and excessive heat. After reconstitution, store according to established handling guidelines and use within the recommended period.

Important Information

CJC-1295 is an investigational peptide and is not approved for the treatment or prevention of any disease in many countries. Distribution and use are subject to applicable laws and regulations. This product should only be supplied and used where legally permitted.